Saatcioglu F, Claret F X, Karin M
Department of Pharmacology, University of California, San Diego, School of Medicine, La Jolla 92093-0636.
Semin Cancer Biol. 1994 Oct;5(5):347-59.
Steroid and thyroid hormones, and vitamins A and D bind to nuclear receptors, which act as ligand-modulated transcription factors. In many cases, ligand-activated nuclear receptor binds to positively acting hormone response elements (p-HREs) to induce gene transcription. However, ligand-activated receptors also repress transcription of specific genes and several mechanisms that account for negative regulation have recently emerged. One major form of negative regulation is based on transcriptional interference between nuclear receptors and other transcription factors, such as AP-1. In this case, the liganded receptor prevents AP-1 or other positively acting transcription factors from fruitful interaction with the transcription initiation complex. A second form of negative regulation is based on binding of nuclear receptors to specialized negative HREs (n-HREs). Binding of unliganded receptor to such an element results in constitutive activation, which is terminated by the binding of ligand. While transcriptional interference with AP-1 has been described for many members of the nuclear receptor family, negative regulation through n-HREs so far has been shown only for one of the thyroid hormone receptors. However, this type of negative regulation is likely to be widespread.
类固醇激素、甲状腺激素以及维生素A和D与核受体结合,这些核受体作为配体调节的转录因子发挥作用。在许多情况下,配体激活的核受体与正向作用的激素反应元件(p-HREs)结合以诱导基因转录。然而,配体激活的受体也会抑制特定基因的转录,并且最近出现了几种解释负向调节的机制。负向调节的一种主要形式基于核受体与其他转录因子(如AP-1)之间的转录干扰。在这种情况下,结合配体的受体阻止AP-1或其他正向作用的转录因子与转录起始复合物进行有效的相互作用。负向调节的第二种形式基于核受体与特殊的负向激素反应元件(n-HREs)的结合。未结合配体的受体与这样一个元件的结合导致组成型激活,这种激活通过配体的结合而终止。虽然对于核受体家族的许多成员都描述了对AP-1的转录干扰,但到目前为止,通过n-HREs的负向调节仅在一种甲状腺激素受体中被发现。然而,这种负向调节类型可能很普遍。